Delivery Order SPE2DE24D0013-SPE2D625F8ES6
- Not listed
- This delivery order, awarded on July 24, 2025, represents a $17,680 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc. for a COVID-19/Influenza/RSV diagnostic kit containing 10 viral tests. The contract is set to be completed by July 31, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This award is issued without a set-aside designation and falls under Cepheid's existing indefinite delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,960 firm fixed-price delivery order to Cepheid Inc. on September 17, 2025, with an ultimate completion date of September 24, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits for infectious diseases,...
- The U.S. Defense Department's Medical Supply Chain awarded a $6.8K delivery order to Cepheid for a molecular diagnostic test kit designed to detect COVID-19, influenza, and respiratory syncytial virus (RSV). The delivery order, issued on August 25, 2025, carries a completion deadline of September 2, 2025, and utilizes firm fixed-price contracting with no set-aside designation. Performance will occur at Cepheid's facility in Sunnyvale, California. Cepheid, a leading provider of molecular...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,272 firm fixed-price delivery order to Cepheid Inc. on September 12, 2025, with an ultimate completion date of September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus detection. Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced molecular diagnostic systems and test kits, will fulfill...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,080 to Cepheid Inc. for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, issued on August 22, 2025, with completion targeted for August 29, 2025, represents a continuation of the Medical Supply Chain's procurement of molecular diagnostic testing capabilities. Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems and...
- Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, received a $6.8K delivery order from the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, for the KIT XPERT XPRESS COVID-19/FLU/RSV + Molecular Biology diagnostic kit. This firm fixed-price delivery order, with performance completion targeted for July 29, 2025, carries no set-aside designation and represents part of Cepheid's ongoing supply of molecular diagnostic testing solutions to...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,488 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, which carries an ultimate completion date of August 13, 2025, will be performed at Cepheid's headquarters in Sunnyvale, California. This award includes no set-aside designation and represents a near-term procurement from the Sunnyvale-based molecular...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, on September 5, 2025, with completion targeted for September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside designation and represents a continuation of Cepheid's...
- The U.S. Defense Department's Medical Supply Chain awarded a $6.8K firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, for a Kit Xpert Xpress COVID-19, Flu, RSV, plus Molecular Biology diagnostic product. The award was issued on July 29, 2025, with an ultimate completion date of August 1, 2025, and carries no set-aside designation. The delivery order will be performed in Sunnyvale, California, leveraging Cepheid's core...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F8ES6Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a $27.2K firm fixed-price delivery order to Cepheid Inc. for the KIT XPERT XPRESS COVID-19, Influenza, and RSV molecular diagnostic kit on July 23, 2025, with completion targeted for July 25, 2025. The contract, which carries no set-aside designation, will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of Cepheid's established role as a primary supplier of molecular diagnostic solutions to federal healthcare systems, particularly supporting rapid infectious disease detection capabilities across defense and veterans health networks. Cepheid is a leading manufacturer of molecular diagnostic systems and reagents specializing in infectious disease testing, including COVID-19, influenza, and RSV detection. The company maintains significant standing relationships with federal agencies through two major Indefinite Delivery/Indefinite Quantity vehicles with the Department of Veterans Affairs, including a $32.8M single-award IDV with VA's Veterans Integrated Service Network 6 that extends through September 30, 2030. This particular delivery order aligns with Cepheid's core product offerings and existing federal contract portfolio, which collectively demonstrate the company's competitive positioning in providing rapid molecular diagnostic capabilities to military medical treatment facilities and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.2k | 7/23/25 |